Apex, NC, United States of America

Daniel Lee Weiner


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Daniel Lee Weiner

Introduction

Daniel Lee Weiner is a notable inventor based in Apex, NC (US). He has made significant contributions to the field of pharmacology through his innovative patent. His work focuses on enhancing the process of drug model generation, which is crucial for the development of effective pharmaceuticals.

Latest Patents

Daniel Lee Weiner holds a patent for an "Interactive graphical environment for drug model generation." This patent discloses a method for interactively constructing pharmacological computational models. A graphical user interface is presented, allowing users to place and connect objects that represent pharmacokinetic and pharmacodynamic elements. As these objects are arranged, they are converted into an internal format that represents the statements of the corresponding computational model. This process enables immediate verification of the model, as the summarized form may include key equations or graphs of user-selected variables.

Career Highlights

Weiner is associated with Pharsight Corporation, where he applies his expertise in pharmacological modeling. His innovative approach has the potential to streamline the drug development process, making it more efficient and effective.

Collaborations

Throughout his career, Daniel has collaborated with notable colleagues, including Michael Robert Dunlavey and David J Hermann. These collaborations have likely contributed to the advancement of his work and the impact of his inventions.

Conclusion

Daniel Lee Weiner's contributions to pharmacological modeling through his patent demonstrate his commitment to innovation in the field. His work not only enhances the understanding of drug interactions but also paves the way for more effective pharmaceutical development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…